|
The device was in use for treatment.A review of the device history record (dhr) was conducted and there were no manufacturing rejects or anomalies of this event type recorded in the dhr.A complaint review of the reported lot identified one additional report for the similar event.Returned device analysis reveals the 6fadelante peel away introducer sheath did not peel in half properly.One adelante peel away introducer sheath was returned from the customer without the dilator.There were no other accessories.Blood was found on the sheath.The sheath was returned in two pieces and the peel along the scoreline was very jagged.Upon evaluation of the returned device, it was found that the sheath failed to peel properly along the scoreline.The peel termination stopped at approximately the halfway point and the rest of the sheath tubing was not returned.The returned portion of the sheath tube exhibited a jagged peel all the way down the body of the sheath and was curled on the sideport tubing half of the sheath.Based on the investigation, a capa is not required.A change request was initiated to implement action to prevent recurrence of this event.Oscor will continue to monitor this event type.The event will be re-evaluated if additional information becomes available.Per qa procedure adelante-s introducer sheath in process and final inspection: break and peel test: using samples from fit check, manually break the sheath and hub, and verify that the seal splits easily without extreme elongation.Also verify that the split cap and seal remain secure and do not break free or loosen from the sheath hub.Manually peel the sheath and verify the sheath peels easily along the sheath body and tip.The instructions for use (ifu) in forms the user: sharply snap the tabs of valve housing in a plane perpendicular to the long axis of the sheath to split the valve and peel sheath apart while withdrawing from the vessel.Oscor inc.Is submitting the above report to comply with 21 cfr part 803, the medical device reporting regulation.The report is based upon information obtained by oscor inc.Which the company may not have been able to investigate or verify prior to the date the report was required by fda.This report does not constitute an admission that the device, oscor inc., or its employees, caused or contributed to the event described in this report.Nor does this report reflect a conclusion by fda, oscor inc., or its employees, that the report constitutes an admission that the device, oscor inc., or its employees caused or contributed to the event described in this report.
|